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ABSTRACT 
 
Aim  
This paper is a report of a study exploring nurses’ views on the benefits of adopting the 
role of prescribing for patients with acute and chronic pain.  
Background 
It was envisioned that the advent of nurse prescribing would be beneficial to the 
efficiency and effectiveness of the United Kingdom National Health Service. Research to 
date does indeed indicate that nurse prescribing can be beneficial to patients, nurses and 
the health service in general.  Despite the expansion of nurse prescribing, there is little 
evidence of its impact according to nurses working in specialist areas, such as with 
patients in acute and chronic pain.  
Method: Interviews were conducted during 2006 and 2007 with 26 nurses qualified to 
prescribe medicines for patients in acute and chronic pain. This was a qualitative study 
and a thematic analysis was conducted.  
Findings: Nurses reported a number of benefits, including faster access to treatment, 
improved quality of care, more appropriate prescribing of medication, improved safety, 
improved relations and communication with patients, greater efficiency and cost 
effectiveness. Nurses benefited from increased job satisfaction, credibility with patients 
and healthcare professionals and also gained knowledge through prescribing. 
Conclusion: There is potential for the benefits of nurse prescribing to be expanded 
beyond the United Kingdom in settings where nurses hold similar roles in the treatment 
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of pain, although further research is recommended to substantiate these findings using a 
wider range of research methods.  
 4 
.  
Keywords 
Nurse prescribing, pain management, qualitative research, interviews, Controlled Drugs 
 
SUMMARY 
 
What is already known about this topic 
 A number of benefits of nurse prescribing have been identified, including 
improved patient care, time-saving, increased job satisfaction and greater 
autonomy for nurses   
 A nursing approach to patient consultation and information-giving is thought to 
result in more holistic patient care during prescribing 
 There is little known about the impact of nurse prescribing for patients with acute 
and chronic pain 
 
What this paper adds 
 Nurses prescribing for patients in pain report similar benefits to those reported by 
nurses working in other therapeutic areas 
 Amongst other benefits, specialist pain nurses report improvements in appropriate 
choice of medication, safety, quality of care, efficiency and cost effectiveness, 
arising from nurse prescribing 
 Autonomy, specialist knowledge and experience, and enhanced consultation skills 
are reported to be central to the benefits of nurse prescribing for patients in pain  
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INTRODUCTION 
The role of nurses in prescribing medicines is continually evolving both in the United 
Kingdom (UK) and internationally. In the UK, nurse prescribing was born out of the need 
to increase efficiency in the National Health Service (NHS) by making best use of its 
resources. Nurse-led services are one means of improving healthcare provision 
(Department of Health (DoH) 1999a, 2000), and a string of legislative change has 
gradually broadened the scope of nurse prescribing in the UK (Courtenay and Carey 
2007).  
 
In the UK, appropriately-qualified community nurses are able to assess, diagnose and 
prescribe independently from a limited list of medicines included in the Nurse 
Prescribers’ Formulary for Community Practitioners. Nurse Independent Prescribers 
(NIPs) (previously known as independent extended prescribers) are similarly able to 
independently assess, diagnose and prescribe any licensed medicine and some Controlled 
Drugs (CDs) that is drugs listed in the schedule to the Narcotics Control Regulations of 
the Controlled Drugs Act, including barbiturates and many opiates (DoH 2005). By 
contrast, Nurse Supplementary Prescribing  (DoH 2002) takes place after assessment and 
diagnosis of a patient’s condition has been made by a doctor, and a Clinical Management 
Plan (CMP) has been drawn up for the patient. The CMP includes a list of medicines 
from which the supplementary prescriber is able to prescribe. Nurse Supplementary 
Prescribers (NSPs) are able to prescribe any medicine (including unlicensed medicines 
and CDs), and this mode of prescribing is best suited to patients with long-term chronic 
conditions. Training for Nurse Independent and Nurse Supplementary Prescribing is 
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combined, i.e. nurses successfully completing the prescribing programme are awarded 
the dual qualification of NIP/NSP. There are now over 10,000 nurses in the UK able to 
prescribe both as NIPs and NSPs (Nursing and Midwifery Council 2007). 
 
The introduction of prescribing is a recent addition to the role of the pain nurse (Stenner 
and Courtenay 2007). Specialist pain nurses play a key role across a variety of settings 
and their role in the safe management of acute and chronic pain has been emphasized 
(Royal College of Anesthetists and the Pain Society 2003). There are specialist pain 
services operating in inpatient and outpatient clinics for acute and chronic pain within 
hospital settings and in primary care facilities. There are also oncology and palliative care 
units within hospitals and on external sites.  
 
Whilst there have been a number of studies of the impact of nurse prescribing, there is a 
lack of research on nurse prescribing of medicines for acute and chronic pain (including 
palliative care settings). Given this lack of information, a qualitative design was chosen 
that would enable us to explore the implementation of nurse prescribing from the point of 
view of nurses.  
 
BACKGROUND 
The potential benefits of nurse prescribing, as set out in the Crown Report (DoH 1999b), 
include: improved use of time on behalf of patients and professionals, improved patient 
care, best use of appropriate skills and improved communication between teams. Similar 
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benefits were anticipated in the guidance on implementing independent prescribing (DoH 
2006): 
 Improved patient care without compromising patient safety 
 Making it easier for patients to get the medicines they need 
 Increased patient choice in accessing medicines 
 Better use of the skills of health professionals 
 Contributing to the introduction of more flexible team working across the NHS  
 
Some of these benefits have been substantiated through research. The nature of the nurse-
patient consultation is a key feature in research on improving patient care. It has been 
reported that patients believe that nurses are more approachable, informative and can be 
more knowledgeable about specific areas than doctors (Luker et al 1997, 1998, Brooks et 
al 2001). Nurses believe that they give more advice to patients about their condition and 
treatment than doctors (Luker and McHugh 2002), and some doctors share this opinion 
(Avery et al 2004). There are indications that prescribing has enabled nurses to achieve 
more holistic patient assessment, resulting in more appropriate treatment (Luker and 
McHugh 2002, Lewis-Evans and Jester 2004). Bradley and Nolan (2007), in a recent 
qualitative study involving interviews with 45 nurse prescribers in the UK, found that 
nurses believed that prescribing complemented their nursing practice, allowing for more 
holistic practice and greater opportunity for patient involvement.  
 
As regards the safety of nurse prescribing, patients and doctors believe that nurses are 
aware of their own limitations and encourage safe practice (Brooks et al 2001, Avery et 
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al 2004). To provide a measure of the quality and safety of nurses’ independent 
prescribing practices, observational case studies were conducted by Latter et al (2007a). 
These researchers found that nurses wrote accurate prescriptions, although there were 
inconsistencies in the application of assessment and diagnostic techniques and detailed 
recordings in patient notes.  
 
Increased patient choice in accessing medicines can occur either by increasing the 
available routes by which patients can access health care or by increasing patient choice 
over treatment options. Whilst it is reported that nurses are prescribing appropriate 
medicine for patients, there is little evidence for improved patient involvement in that 
choice (Latter et al 2007b). However, improvements have been reported in the timeliness 
and convenience of patient access to medicines (Luker et al, 1998, Brooks et al 2001, 
Luker and McHugh 2002, Latter and Courtenay 2004, Lewis-Evans and Jester 2004). 
Increased nurse autonomy and reduced dependency on doctors (Rodden 2001, Bradley 
and Nolan 2007), may in turn, help to improve the scope and efficiency of nurse-led 
services.  
There are indications that nurse prescribing makes better use of nurses’ and 
doctors’ time and skills, increases nurse job satisfaction and improves professional 
relationships (Avery et al 2004, Latter et al 2005, Bradley and Nolan 2007). Increased 
autonomy and decreased dependence on doctors by nurse prescribers also has a postivie 
impact on team relationships (Rodden 2001, Bradley and Nolan 2007).  
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A substantial amount of the early research focused on the impact of prescribing in 
relation to community nurses (district nurses and health visitors). Other research has 
reported anticipated benefits to areas where nurses were not yet prescribing (Nolan et al 
2001, Hay et al 2004, Bradley et al 2005, Pontin and Jones 2007). Research specific to 
nurse prescribing for patients in pain is lacking, although there is some evidence about 
the role of pain nurses in general. A survey of over 3000 nurses working with patients 
with acute and chronic pain in hospital settings in the United States of America showed 
that nurses were involved in assessment, monitoring, evaluating and pain management 
(Pellino et al 2002). Data collected from 100 Advanced Nurse Practitioners in Canada by 
questionnaire (Kohr and Sawhney 2005) and interview data from 15 nurses working in 
the post-operative pain setting in Sweden (Soderhamn and Idvall 2003) indicate that 
nurses also play an important role in advising and influencing medical decisions about 
prescribing for pain. In the UK, a questionnaire survey of 103 nurse members of the Pain 
Society was conducted to explore nurses’ beliefs about pain management and their 
understanding of the roles of members of the pain team (Brown and Richardson 2006). 
Interdisciplinary team working and collaboration were identified as central to the role of 
these nurses. Similar findings were reported by Johnston and Smith (2006) in a 
qualitative study exploring the concept of palliative care and the role of palliative care 
nurses. They conducted 44 interviews with nurses and patients working in acute and 
hospice settings in Scotland and found that a cohesive multidisciplinary team was 
considered to be a key factor in effective palliative care nursing.  
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No evidence is currently available on pain nurses’ views on the adoption of prescribing in 
their practice. This is important as there is a continual need for research to inform and 
shape this area of work as it expands to different areas of nursing practice. At the time of 
writing, views were being sought on proposals to expand the range of Controlled Drugs 
that can be prescribed by Nurse Independent Prescribers (Home Office 2007). It is 
therefore important to understand the role that nurses play in prescribing for patients in 
pain.   
 
THE STUDY 
 
Aim 
The study aim was to explore nurses’ views on adopting the role of prescribing for 
patients with acute and chronic pain.  
 
Findings relating to further study objectives are reported elsewhere (Stenner and 
Courtenay 2007).  
 
Design 
A qualitative design was selected, using semi-structured interviews and thematic analysis. 
The data were collected in 2006-07.  
 
Participants 
The participants were purposively sampled from two nationally-recognised groups of 
specialist pain nurses in England.  They were 26 nurses, qualified in NIP and NSP, who 
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worked in acute and chronic (including palliative) pain services in a range of UK work 
settings, and included clinical nurse specialists in pain (n=15), Macmillan nurses (charity 
funded cancer nurses) (n=2), pain consultants (n=6), clinical nurse managers (n=2) and a 
lead pain nurse (i.e. a nurse working in this specialist area and responsible for leading and 
developing a nursing team). The majority of participants (19) worked in hospital inpatient 
and/or outpatient settings and treated mixed pain types (i.e. acute, chronic and palliative 
pain), two worked in a hospital outpatient department managing chronic pain and one in a 
walk-in-centre managing acute and chronic pain. A further 3 participants provided 
community home care and managed palliative pain, and one worked in a hospice and 
managed palliative pain. 
 
Data collection 
Audio-recorded, face-to-face, semi-structured interviews lasting 30-50 minutes were held 
in quiet locations convenient to participants. The interview schedule was informed by a 
review of the relevant literature and national work in the area of nurse prescribing 
(Courtenay and Carey 2007, Latter et al 2005). The interview schedule covered general 
views on nurse prescribing, role changes resulting from prescribing, difficulties in 
prescribing, enabling factors in prescribing, support and supervision, educational needs, 
views on NSP and views on the prescribing training course.  
 
Ethical considerations 
The study was approved by the appropriate university and NHS ethics and research 
governance committees. Information about the study was distributed to members of the 
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two national pain groups and those interested in participating were recruited by the group 
organisers. Contact details were then passed to us and we provided further information to 
potential participants and answered queries about the project. Consent was obtained prior 
to interview and participants were free to withdraw from the study at any time. 
Transcripts were anonymised by removing identifying features.  
 
Data analysis 
Thematic data analysis was conducted. The process was data driven, or inductive, in that 
a coding frame was developed on the basis of the data rather than being pre-determined 
by theory (Patton 1990). Initial coding and identification of patterns across the data were 
aided by the use of the ATLAS.ti qualitative data analysis software package. A further 
process of interpreting the broader meanings and significance of the patterns in the data 
was used to identify overarching themes and sub-themes.  
 
Rigour 
The coding frame was independently assessed by an additional qualitative researcher. 
Saturation was achieved in that we were able to categorise the later interview data within 
the existing coding frame without needing to add new codes. The main findings were 
presented to pain nurses at a pain network meeting in May 2007 and a nurse pain 
consultant meeting in June 2007. A high level of agreement and acknowledgement of the 
relevance of the findings were reported.  
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FINDINGS 
Autonomy 
Autonomy, the sense of being free to make informed prescribing decisions, was the key 
concept behind a number of benefits to nurse prescribing in pain.  
 
Faster access to treatment 
Improved speed and convenience of access to medicines for patients was reported as a 
key benefit. In acute settings, patients were reported to have regularly experienced delays 
in receiving medication advised by specialist pain nurses before the nurses took on the 
prescribing role. Greater autonomy over prescribing enabled nurses to overcome these 
delays by prescribing immediately and planning for faster access to medication: 
 
“I would have advised the same medications that I now can prescribe, but the 
difference is that often I would advise something, go back the next day to see if 
what I had advised had worked to find that it had never been implemented. So you 
would be 24 hours down the line with no advance, whereas this way I can 
prescribe it, I can ensure that the pharmacist knows, it’s up on the wards, it’s 
ready, raring to go and we’re 24 hours ahead of ourselves.”  
 
Improved safety 
Misinterpretations had occurred previously, where nurses recommended medication but 
could not prescribe.  Prescribing was believed to improve safety by ensuring that the 
person assessing the patient had responsibility for prescribing the medication advised. 
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Importantly, a good knowledge base was considered necessary for prescribing CDs, and 
therefore any improvements in care were dependent upon the level of specialist 
knowledge and experience. Nurses described a process of demarcating those medicines 
they were competent and comfortable to prescribe. In some cases, drawing up an ‘intent 
to prescribe’ (listing the types of medication the nurse was able to prescribe), helped to 
formalize this process and was useful for explaining the limitations of practice to 
colleagues. Nurses in general were considered to be more cautious over safety in 
prescribing than junior medical doctors, who were seen to be regularly under pressure to 
prescribe outside of their area of competence:   
 
“I feel it is a lot safer because we know the side-effects, we know the way that the 
drugs work - all my team have got a Master’s in pain management so we 
understand the drugs and the pharmaco-kinetics and pharmaco-dynamics of it … 
so we feel it has made it a lot safer because a lot of the medical colleagues don’t 
understand the way that opioids work.” 
 
Appropriate prescribing and quality of care 
Clinically-inappropriate prescribing of CDs had been noted by participants. Lack of 
experience and fear of prescribing CDs were the reasons given as to why some healthcare 
professionals prescribed inadequate doses. The most common was misjudging the 
appropriate strength of pain medication, which resulted in either over- or under-
prescribing.  Other problems occurred in identifying contraindications and drug 
interactions, neglecting to take patients’ views into account, making errors in drug 
calculations and sudden withdrawal of medication.  
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Nurses reported that combining specialist skills, experience and knowledge of pain 
medication, together with a comprehensive patient assessment, enabled them to make 
more clinically-appropriate prescribing decisions. In other words, they reported an ability 
to choose products accurately and tailor medication to best suite a patient’s condition, 
circumstances and medical history. Making the right choice of medication was believed 
to improve patients’ trust in the service received, thus influencing concordance as well 
improving clinical and cost effectiveness:  
 
“We see that a lot of the time with a lot of the junior doctors because they will 
under prescribe Oramorph®, for instance, and then we come along and change the 
prescription and speak to them and say, ‘Actually this dose, 5-10 milligrams, is 
completely inadequate - the dose is such and such’. So yes, there is definitely 
stigma attached to Controlled Drugs.” 
 
“Often when GPs initiate a controlled drug, say slow release morphine or a 
fentanyl patch, they will initiate it at quite a high dose and, of course, if they do 
that the patient is more at risk of getting side effects. And then you have lost the 
patient’s confidence in that particular drug, even though it may be better for the 
patient at a lower dose.  I think that is often an advantage - when we go in and 
review the patient and what previous analgesia they have had and the conversion 
rate to morphine or whatever drug - that you choose to get the dose right and 
maintain the patient’s confidence in the drug.” 
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Furthermore, where nurses were able to follow up and re-evaluate patients, they said that 
they were better able to alter medication in response to patient need. Examples were 
given whereby such increased autonomy over medicines management had, according to 
the nurse, improved patient care as well as being cost-effective:  
 
“You can be very responsive with patients and if you are titrating between 
[drugs], because I know that I can get back to see them in a week or ten days. I 
would make that appointment there and then. I would perhaps only prescribe them 
that number of tablets, or perhaps a few extra, so I think it is quite cost effective 
from the GP’s point of view.”  
 
Improved relations and communication with patients 
Because prescribing enabled nurses to deliver a complete episode of care, this was 
believed to enhance the relationship between patient and nurse, thus having an impact on 
care. Increased autonomy meant that nurses could be more confident about when, what 
and how patients were medicated. As a result, nurses said that they were better able to 
communicate with patients about their medication, improving patient confidence and 
concordance:  
 
“It’s just fantastic now that you can say to patients, ‘Just bear with me, I’ll be a 
few minutes, we’ll get this sorted out and we’ll get on top of your pain’. Whereas 
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before I didn’t feel confident enough to be able to say that to the patients because 
I knew all the frustrations that I was going to have to be able to get that job done.” 
 
The partnership between prescriber and patient was seen as an important factor in 
prescribing CDs. This involved discussing and agreeing a course of action with the 
patient in line with their medical history and past use of CDs. It was believed that patients 
gained a better understanding of their medication, the reasons for taking it and the correct 
regime for taking it when it was prescribed by a nurse. It was suggested that differences 
in training and longer appointment times meant that nurses held more detailed and 
comprehensive consultations with patients, including giving better advice and 
explanations and more often acting on patient preferences. These perceived differences 
between doctor and nurse consultations were thought to further enhance patient care 
when combined with nurse prescribing:  
 
“I think because we have a longer period of time spent with the patient we have 
got more time to actually explain things in more detail and, you know, I think to 
… we have better communication skills because of the training we have had in the 
subject. And, you know, it’s as much about relationship with the patient as giving 
information.” 
 
Greater efficiency and cost-effectiveness 
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In addition to time saving, increased efficiency resulted from developing a more seamless 
service and enhancing working relationships within teams.  For those working in the 
community, autonomy in prescribing reduced the need to gain approval from large 
numbers of GPs, although nurses continued to communicate with GPs about medicines 
they had prescribed. By improving access to medication, some nurses believed they had 
prevented hospital admissions or speeded the recovery of patients to enable earlier 
discharge from hospital. Nurse prescribing resulted in fewer interruptions to the care 
process for patients and was expected to reduce waiting times.  
 
“With the way that the NHS is going, with getting patients out of secondary care 
quicker, you know, it has been really highlighted to me that the acute pain team 
and their nurse prescribing skills is paramount to that. Because if patients are in 
pain they can’t do their physiotherapy, they can’t go home, and getting patients 
home fairly quickly so they don’t get infections etc. is really important, and that’s 
been highlighted by management”. 
 
Nurses working in hospitals reported variations in the prescribing practice of different 
clinical teams and junior doctors. Through promotion of evidence-based medicine, nurses 
believed that they introduced greater consistency in prescribing practice. More 
appropriate evidence-based choice of medication by nurse prescribers was believed to 
result in less drug wastage, lower cost and better concordance. On the whole, nurses were 
aware of the cost implications of different drugs, particularly those who were involved in 
local policy or decision-making. Nurses reported that, where evidence showed more than 
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one drug to be effective, they would prescribe cheaper drugs as the first choice unless 
there was a good rationale for prescribing a more expensive drug, for example if the 
patient was opiate-resistant or unable to take medication in the usual way:   
 
“Cost is important. I wouldn’t hesitate to use an expensive opioid such as 
oxycodone with a patient who had already had a bad experience on morphine, but 
I would on someone who hadn’t. So I’d start with the cheap and simple and then 
work my way through to the more expensive and ‘ritzy’, as it were. So cost 
does… it’s that pyramid of prescribing - you want something safe and effective 
but it’s also got to be cost-effective as well.”  
 
Increased job satisfaction 
Increased job satisfaction was consistently reported as an outcome of gaining autonomy 
and being able to complete episodes of care. It was also linked to the ability to overcome 
previous frustrations with the healthcare system and to make use of existing knowledge 
and skills, and to gaining confidence, witnessing positive outcomes and providing a more 
rounded quality care for patients:   
 
“We wonder how we ever managed beforehand, because it gives us satisfaction 
because we’re doing the holistic care. We have always assessed our patients and 
made a diagnosis, and now we can prescribe and then we can actually follow it 
up.” 
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Gaining knowledge through prescribing 
Prescribing did more than simply enable nurses to make better use of existing knowledge 
- it was also said to facilitate new learning. Nurses were continually learning from the 
process of prescribing, particularly where they were able to re-evaluate medications at 
follow-up sessions. Examples included learning about the effects of medication for a 
range of different patients, increasing knowledge of side effects and drug reactions, and 
increased knowledge of symptom control. Regular supervision time to review patient 
outcomes and discuss medicine interactions was reported to support this continual 
learning process: 
 
“I think that when we are prescribing it gives us continuity of knowledge in that 
you know what the patients had because you prescribed it…  I have learnt from 
the effects of drugs. Having taken the responsibility, I have learnt more about how 
that drug affects the patient, whereas before perhaps I wasn’t as aware and maybe 
didn’t pay it as much attention.” 
 
The act of prescribing itself encouraged continuous learning about drug interactions and 
side effects. Participants commonly described becoming more cautious and vigilant once 
they had passed the prescribing qualification and taken on direct responsibility for 
prescribing. This ‘transition effect’ from novice to expert was accompanied by systematic 
reviewing of patient notes, checking for contraindications or side effects and double-
checking dose calculations and prescriptions for errors:  
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“I’m always learning new stuff. When you take that responsibility of suddenly 
putting your name to it, you know, you’re always checking – Does that interact 
with something else? Have I gone through the patient’s notes to find every inch of 
past medical history that might be relevant? It does make you... I think, look at the 
patient a little bit more holistically and look for every detail, because you know 
you need to know it all.”  
 
Increased credibility and confidence to make recommendations 
Having the prescribing qualification on some occasions increased nurse credibility in 
relation to other nurses, junior doctors, GPs, physicians and patients. This was important 
to the nurses who were recommending medication. Having a recognized qualification and 
demonstrating willingness to take responsibility for prescribing helped to smooth 
relations between professionals. Other nurses felt that the nurse prescriber’s status and 
credibility was little changed, mainly because they were already highly regarded before 
becoming a prescriber: 
 
“I think that you are more credible… as a prescriber. I know GPs have been more 
comfortable with advice coming out of pain clinic because I can put [a prescribing 
qualification] after my name. Whereas when I started and I didn’t have a 
prescribing qualification, we had a few comments from local GPs to my medical 
boss saying, ‘What makes her qualified to advise me?’ And he says it’s been 
much easier to say, ‘Well, of course my nurse is qualified to prescribe’.” 
 
 22 
 
DISCUSSION 
The findings of this study indicate that the benefits of nurse prescribing for patients in 
pain are comparable to those identified in other therapeutic areas in which nurses 
prescribe medicines. These benefits are in line with those predicted for nurse prescribing 
(DoH 1999b, 2006), but give deeper insight into the mechanisms by which some of these 
benefits arise.  
 
In the context of pain, autonomy was defined by the degree to which nurses had control 
over assessing, diagnosing and making decisions about a patient’s medication. Prior to 
the introduction of nurse prescribing, lack of autonomy hampered practice. Although 
nurses were able to recommend to doctors that certain medicines should be prescribed, 
these recommendations were not always followed through. This caused delay and 
interruption to treatment management. Through prescribing, nurses believed they were 
able to improve convenience and speed of access to treatment, provide more continuous 
care, increase efficiency and clinical effectiveness. Autonomy also benefited nurses by 
improving job satisfaction and making better use of nurses’ knowledge and skills. 
Furthermore, our findings show that the actual process of prescribing can benefit nurses 
as the continual need to update knowledge generated an accelerated learning process 
where there was a supportive learning environment.   
Through practising autonomously, pain nurses were able to overcome existing 
inadequacies in the healthcare system, such as limited access to a specialist prescriber. 
Improvements to safety and quality of care occurred by avoiding or correcting clinically- 
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inappropriate prescribing by non-specialists. Indications of poor understanding and 
sometimes fear of prescribing controlled drugs amongst less experienced healthcare 
professionals highlights the need for more comprehensive training for a range of these 
personnel. Specialist pain nurses may have a role to play in that training.   
Whilst some of these benefits were reliant on the level of specialist knowledge 
and expertise nurses had about pain, other benefits were associated with skills considered 
particular to the nursing profession. The implied superiority of the nurse--patient 
consultation in terms of communication and information exchange has been consistently 
reported (Luker et al 1998, Brooks et al 2001, Luker and McHugh 2002, Avery et al 
2004, Lewis-Evans and Jester 2004). However, it is when these so called nursing skills 
meet with the skills and expertise required for prescribing that a grander picture emerges. 
As reported by Bradley and Nolan (2007), nurses have adopted prescribing alongside 
more traditional approaches to nursing as a caring role in order to provide more rounded 
holistic care. It may well be that benefits such as improved concordance, safety and 
efficient prescribing, arise from combining prescribing expertise with more traditional 
nursing roles and holistic approaches to health care.  
In this study, patient-centred approaches and the principles of concordance were 
considered especially important when prescribing controlled drugs for patients in pain. 
The principles of concordance include achieving a partnership between prescriber and 
patient that enables agreement to be reached over the way in which an illness is 
understood and treated (Latter 2007b). Nurses believed that their consultation skills, 
along with their knowledge and expertise, enabled prescribing decisions to be more 
appropriate to patients’ individual needs. Prescriptions were more likely to be effective in 
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the first instance and patients were better equipped with the knowledge and 
understanding needed to adhere to treatment. However, nurse opinions about the 
effectiveness of their prescribing practice are only part of the story. In research on 
concordance, Latter (2007b) found that whilst nurse prescribers and their patients thought 
the principles of concordance were being practised by nurses, they were not always 
evident to a high degree in observation of practice. Similarly, Latter et al (2007a), in a 
study of 14 case study sites across the UK, identified that nurse prescribers were 
inconsistent in enquiring about allergies or use of over-the-counter medication, and did 
not always record comprehensive details in patient notes. These findings demonstrate the 
need for further research using a range of outcome measures to study nurse prescribing, 
rather than relying on self-report methods.  
Findings from our broader study highlighted what nurses considered to be the 
difficulties of nurse prescribing in this area and are reported elsewhere. Relevant to this 
paper are the importance of a supportive environment, access to suitable education and 
the indication that barriers such as cost and access to patient records are preventing 
benefits from occurring for outpatients in chronic pain (Stenner & Courtenay 2007).  
 
Study limitations 
 
This was a small study involving self-reported benefits from 26 nurse prescribers who 
were mainly pain specialists and were mostly working in hospital settings. Further 
research is needed on the role of generalist nurses prescribing for patients in pain and on 
the views of doctors, pharmacists and patients.  
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CONCLUSION 
There is potential for the benefits of nurse prescribing to be expanded beyond the UK in 
settings where nurses hold similar roles in the treatment of pain, although further research 
is recommended to substantiate these findings using a wider range of research methods 
and outcome measures other than self-report.   
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